Neoadjuvant systemic chemotherapy for patients with operable breast cancer
Zhang, B.; Zhang, Q.
Zhonghua Zhong Liu Za Zhi 29(3): 161-165
2007
ISSN/ISBN: 0253-3766 PMID: 17649628 Document Number: 609937
Document emailed within 1 workday
Related Documents
Franceschini, G.; Di Leone, A.; Natale, M.; Sanchez, M.A.; Masett, R. 2018: Conservative surgery after neoadjuvant chemotherapy in patients with operable breast cancer Annali Italiani di Chirurgia 89: 290Botti, C.; Vici, P.; Lopez, M.; Scinto, A.F.; Cognetti, F.; Cavaliere, R. 1995: Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast Journal of the American College of Surgeons 181(3): 202-208
Stamatovic, L.; Susnjar, S.; Gavrilovic, D.; Minic, I.; Ursulovic, T.; Dzodic, R. 2018: The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients Journal of Buon: Official Journal of the Balkan Union of Oncology 23(5): 1273-1280
Horiguchi, J.; Oyama, T.; Takata, D.; Rokutanda, N.; Nagaoka, R.; Odawara, H.; Tokiniwa, H.; Tozuka, K.; Kikuchi, M.; Sato, A.; Takeyoshi, I. 2011: Pathological complete response and prognosis in patients receiving neoadjuvant paclitaxel and trastuzumab with and without anthracyclines for stage II and III, HER2-positive operable breast cancer: a single-institute experience Anticancer Research 31(9): 3041-3046
Mamounas, T.P. 2013: Predicting locoregional recurrence after neoadjuvant chemotherapy in patients with breast cancer Clinical Advances in Hematology and Oncology: H&o 11(3): 175-177
Su, J.; Chen, H.; Li, M.; Dong, J.; Lin, Z. 2015: Value of FOXP3 Tregs predicting the effectiveness of neoadjuvant chemotherapy in patients with breast cancer Zhonghua Yi Xue Za Zhi 95(8): 595-597
Sun, B.; Song, S.-t.; Wu, S.-k.; Jiang, Z.-f.; Wang, T.; Zhang, S.-h.; Zhao, Y.-b.; Yu, C.-z.; Li, X.-b.; Yang, T.; Li, G.-j. 2009: Comparison of response evaluation methods of neoadjuvant chemotherapy in breast cancer patients Zhonghua Zhong Liu Za Zhi 31(10): 783-785
Rossi, A.; Valagussa, P.; Bonadonna, G. 1977: Surgery and adjuvant chemotherapy in the treatment of operable breast cancer Progress in Clinical and Biological Research 12: 391-404
Conti, F.; Sergi, D.; Foggi, P.; Abbate, M.I.; Lopez, M. 2007: New combination chemotherapy regimens in the primary treatment of operable breast cancer La Clinica Terapeutica 158(1): 55-75
Litviakov, N.V.; Garbukov, E.I.; Slonimskaia, E.M.; Tsyganov, M.M.; Denisov, E.V.; Vtorushin, S.V.; Khristenko, K.I.; Zav'ialova, M.V.; Cherdyntseva, N.V. 2013: Correlation of metastasis-free survival in patients with breast cancer and changes in the direction of expression of multidrug resistance genes during neoadjuvant chemotherapy Voprosy Onkologii 59(3): 334-340
Timovska, Y.O.; Pivnyuk, V.M.; Oliynichenko, G.P.; Anikushko, M.F.; Zachartseva, L.M.; Chekhun, V.F. 2009: Relation between pathomorphological response in tumors after neoadjuvant chemotherapy and clinico-morphological and molecular prognostic factors in patients with breast cancer Experimental Oncology 31(4): 231-236
Shahzad, R.; Masood, M.; Shahid, A.; Mirza, Z.R.; Cheema, F.E.; Fatima, I. 2019: Sonographically guided metalic clip placement for tumour localization in early breast cancer patients undergoing neoadjuvant chemotherapy JPMA. Journal of the Pakistan Medical Association 69(10): 1501-1504
Senn, H.J. 1985: Have therapeutic measures improved the prognosis of operable breast cancer? Adjuvant chemotherapy Verhandlungen der Deutschen Gesellschaft für Innere Medizin 91: 421-428
Hooning, M.J.; van Dongen, J.A.; Went, G. 1991: Changing indications for breast conserving therapy: proportion of patients with operable breast cancer suitable for breast conservation Netherlands Journal of Surgery 43(4): 102-104
Brain, E.G. 2000: Neoadjuvant chemotherapy in the treatment of breast cancer Annales de Medecine Interne 151(3): 215-219
Taguchi, T. 2012: The development of neoadjuvant chemotherapy in breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(6): 876-881
Bear, H.D. 1998: Indications for neoadjuvant chemotherapy for breast cancer Seminars in Oncology 25(2 Suppl 3: 3-12
Li, J-Feng.; Ouyang, T.; Wang, T-Feng.; Lin, B-Yao. 2004: Neoadjuvant chemotherapy for primary breast cancer Zhonghua Zhong Liu Za Zhi 26(8): 493-495
Avci, N.; Deligonul, A.; Tolunay, S.; Cubukcu, E.; Fatih Olmez, O.; Ulas, A.; Hartavi, M.; Kurt, E.; Evrensel, T. 2015: Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 20(1): 45-49
Hafiz, F.; Choudhury, T.; Kamal, M.; Banu, S.G. 2014: The spectrum of pathological changes in breast cancer following neoadjuvant chemotherapy Mymensingh Medical Journal: Mmj 23(2): 272-280